Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Anxa8em1flox/Cya
Common Name:
Anxa8-flox
Product ID:
S-CKO-17794
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Anxa8-flox
Strain ID
CKOCMP-11752-Anxa8-B6J-VB
Gene Name
Anxa8
Product ID
S-CKO-17794
Gene Alias
Anx8
Background
C57BL/6JCya
NCBI ID
11752
Modification
Conditional knockout
Chromosome
14
Phenotype
MGI:1201374
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Anxa8em1flox/Cya mice (Catalog S-CKO-17794) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000022519
NCBI RefSeq
NM_013473.4
Target Region
Exon 2
Size of Effective Region
~0.6 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Anxa8, a member of the annexins family, encodes an anticoagulant protein involved in the blood coagulation cascade and acts as an indirect inhibitor of the thromboplastin-specific complex [3]. It has been associated with multiple cellular processes including proliferation, metastasis, and inflammation, and is involved in signaling pathways such as EGFR-Akt-mTOR, Wnt/β-catenin, and the regulation of cell cycle-related proteins [2,4].

In various diseases, Anxa8 shows distinct roles. In gastric carcinoma, its over-expression is strongly correlated with TNM stages, differentiation grades, and is an independent prognostic factor for overall survival and disease-free survival, acting as an oncogene [1]. In non-small lung cancer cells A549, over-expression of Anxa8 promotes proliferation and migration via the EGFR-Akt-mTOR signaling pathway, while knockdown has the opposite effect [2]. In porcine endometrial cells, Anxa8 promotes proliferation through the Akt signaling pathway [3]. In ovarian cancer, interference with Anxa8 inhibits malignant progression by suppressing the activation of the Wnt/β-catenin signaling pathway via UCHL5 [4]. In atherosclerosis-prone mice, germline deletion of Anxa8 decreases atherosclerotic burden, plaque size, and macrophage accumulation, and endothelial-specific silencing of Anxa8 also reduces atherosclerosis progression, indicating that Anxa8 promotes atherosclerosis progression by modulating endothelial-leukocyte interactions [5]. In renal cell carcinoma, Anxa8 expression is increased and associated with poor prognosis, and knockdown of Anxa8 mainly influences the cell cycle and DNA replication [6]. In cholangiocarcinoma, ANXA8 inhibits cell migratory and metastatic characteristics, and its down-regulation by EGF-FOXO4 signaling is involved in tumor metastasis [7]. In cervical squamous cell carcinoma, the TFAP2A/Anxa8 axis regulates ferroptosis by mediating GSH synthesis [8].

In conclusion, Anxa8 is involved in multiple biological processes and disease conditions. Gene knockout or knockdown studies in various models have revealed its role in processes like cell proliferation, metastasis, and in diseases such as cancer and atherosclerosis. These studies provide insights into potential therapeutic strategies targeting Anxa8 for treating related diseases.

References:
1. Ma, Fangqi, Li, Xiaowei, Fang, Haiming, Sun, Qin, Li, Xuejun. 2020. Prognostic Value of ANXA8 in Gastric Carcinoma. In Journal of Cancer, 11, 3551-3558. doi:10.7150/jca.40010. https://pubmed.ncbi.nlm.nih.gov/32284751/
2. Zhou, G-Z, Sun, Y-H, Shi, Y-Y, Cui, L-Q, Sun, G-C. . [ANXA8 Regulates Proliferation of Human Non-Small Lung Cancer Cells A549 via EGFR-AKT-mTOR Signaling Pathway]. In Molekuliarnaia biologiia, 55, 870-880. doi:10.31857/S0026898421050116. https://pubmed.ncbi.nlm.nih.gov/34671007/
3. Jiang, Xiaona, Xue, Songyi, Kang, Tingting, Ni, Debin, Lei, Minggang. 2018. Annexin A8 (ANXA8) regulates proliferation of porcine endometrial cells via Akt signalling pathway. In Reproduction in domestic animals = Zuchthygiene, 54, 3-10. doi:10.1111/rda.13280. https://pubmed.ncbi.nlm.nih.gov/30040162/
4. Xu, Li, Wang, Liang, Gan, Yaping, Ning, Yingxia, Feng, Weifeng. 2024. Interference with ANXA8 inhibits the malignant progression of ovarian cancer by suppressing the activation of the Wnt/β-catenin signaling pathway via UCHL5. In Aging, 16, 11275-11288. doi:10.18632/aging.205991. https://pubmed.ncbi.nlm.nih.gov/39068672/
5. Gutiérrez-Muñoz, Carmen, Blázquez-Serra, Rafael, San Sebastian-Jaraba, Irene, Méndez-Barbero, Nerea, Blanco-Colio, Luis M. . Annexin A8 deficiency delays atherosclerosis progression. In Clinical and translational medicine, 15, e70176. doi:10.1002/ctm2.70176. https://pubmed.ncbi.nlm.nih.gov/39835780/
6. Wang, Li-Hui, Cao, Bo, Li, Yun-Long, Qiao, Bao-Ping. 2023. Potential prognostic and therapeutic value of ANXA8 in renal cell carcinoma: based on the comprehensive analysis of annexins family. In BMC cancer, 23, 674. doi:10.1186/s12885-023-11165-x. https://pubmed.ncbi.nlm.nih.gov/37464398/
7. Lee, Mi-Jin, Yu, Gyung-Ran, Yoo, Hee-Jung, Choi, Yang-Kyu, Kim, Dae-Ghon. 2009. ANXA8 down-regulation by EGF-FOXO4 signaling is involved in cell scattering and tumor metastasis of cholangiocarcinoma. In Gastroenterology, 137, 1138-50, 1150.e1-9. doi:10.1053/j.gastro.2009.04.015. https://pubmed.ncbi.nlm.nih.gov/19376120/
8. Sheng, Yuehua, Ding, Huiqing, Zhou, Jiaqing, Yang, Fan, Du, Yongming. 2024. The effect of TFAP2A/ANXA8 axis on ferroptosis of cervical squamous cell carcinoma (CESC) in vitro. In Cytotechnology, 76, 403-414. doi:10.1007/s10616-024-00619-0. https://pubmed.ncbi.nlm.nih.gov/38933875/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest